The company was established in Europe in United Kingdom. The main department of described VC is located in the Bath.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Sulis Innovation, startups are often financed by Quester Capital, Nesta Ventures. The meaningful sponsors for the fund in investment in the same round are Quester Capital, Nesta Ventures, YFM Equity Partners. In the next rounds fund is usually obtained by Parkwalk Advisors, Nesta Ventures, YFM Equity Partners.
The important activity for fund was in 2003. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. This Sulis Innovation works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2011. The common things for fund are deals in the range of 100 thousands - 1 million dollars.
For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Micrima, Lectus Therapeutics. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Medical Device.
Related Funds
Funds with similar focus
Fund Name | Location |
cultivate(MD) | Holland, Michigan, United States |
Lubbock Angel Network | - |
Nivelinvest | Belgium, Louvain-la-neuve, Vlaams-Brabant |
SB ISAT | - |
Shenzhenshi Zhonggen Touzi Youxian Gongsi | China, Futian, Guangdong |
SPIC | Beijing, Beijing, China |
Startup Angels Network | Gurgaon, Haryana, India |
The 6ixth Event | Kentucky, Louisville, United States |
The Vedas Group | New York, New York, United States |
Zeyu Capital | China, Guiyang, Guizhou |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Symetrica | $1M | 01 May 2007 | England | ||
Lectus Therapeutics | 03 Nov 2003 | England | |||
01 Jan 2002 | Bristol Township, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Symetrica | $1M | 01 May 2007 | England | ||
Lectus Therapeutics | 03 Nov 2003 | England | |||
01 Jan 2002 | Bristol Township, Pennsylvania, United States |